RESERVOIR 44111 VENTRICULAR BURR HOLE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,o report with the FDA on 2018-12-28 for RESERVOIR 44111 VENTRICULAR BURR HOLE manufactured by Medtronic Neurosurgery.

Event Text Entries

[131635025] If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[131635026] It was reported the patient was implanted with the reservoir in mid (b)(6) 2016. On (b)(6) 2018, the patient underwent a drug infusion. On (b)(6), the patient had a fever and was vomiting. The emergency department observed rigidity of the patient? S neck and swelling of the reservoir. Also, the patient seemed to have pain when touching the reservoir and alternate episodes of drowsiness. Grade 3 meningitis was suspected and a blood test was performed with normal result (short evolution time). A cerebrospinal fluid (csf) sample was obtained from the reservoir, which was turbid. The hospital admission was decided and intravenous antibiotic therapy with cefotaxime and vancomycin was started. On (b)(6), in the morning the patient only presented with low-grade fever. Given that the analysis of csf including gram was negative, it was decided to perform a lumbar puncture that showed cell elevation (around 1000/ml) at the expense of polymorphonuclear cells and hypoglycorrhachia. It was decided to remove the (b)(4) device by surgery on (b)(6) and the patient continued with intravenous antibiotics for approximately 15 days pending the result of the cultures. A brain nuclear magnetic resonance imaging was also performed and it did not show significant alterations or intracranial complications such as abscess or obstruction to the circulation of cerebrospinal fluid. The outcome of the event was reported as recovering/resolving. It was stated the patient's (b)(4) device and the procedural puncturing of the device may have contributed to the event. It was further stated that based on the information provided, meningitis was not suspected to be caused by the study drug.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2021898-2018-00595
MDR Report Key8203277
Report SourceFOREIGN,HEALTH PROFESSIONAL,O
Date Received2018-12-28
Date of Report2019-01-11
Date of Event2018-11-14
Date Mfgr Received2019-01-02
Device Manufacturer Date2015-12-14
Date Added to Maude2018-12-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTACY RUEMPING
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635260594
Manufacturer G1MEDTRONIC NEUROSURGERY
Manufacturer Street125 CREMONA DRIVE
Manufacturer CityGOLETA CA 93117
Manufacturer CountryUS
Manufacturer Postal Code93117
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameRESERVOIR 44111 VENTRICULAR BURR HOLE
Generic NamePORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVENTRICULAR
Product CodeLKG
Date Received2018-12-28
Model Number44111
Catalog Number44111
Lot NumberE05469
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROSURGERY
Manufacturer Address125 CREMONA DRIVE GOLETA CA 93117 US 93117


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2018-12-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.